TY - JOUR
AU - A. M. Lott
AU - A. N. Danner
AU - C. A. Malte
AU - E. C. Williams
AU - A. J. Gordon
AU - M. A. Halvorson
AU - A. J. Saxon
AU - H. J. Hagedorn
AU - G. G. Sayre
AU - E. J. Hawkins
A1 - 
AD - From the Center of Excellence in Substance Addiction Treatment and Education, VA Puget Sound Health Care System, Seattle, WA (AML, AND, CAM, AJS, EJH); Seattle Center of Innovation for Veteran-Centered and Value-Driven Care, Health Services Research and Development, Veterans Affairs (VA) Puget Sound Health Care System, Seattle, WA (AML, AND, CAM, ECW, AJS, GGS, EJH); Department of Health Systems and Population Health, University of Washington, Seattle, WA (ECW); Informatics, Decision-Enhancement, and Analytic Sciences Center, Health Services Research and Development, VA Salt Lake City Health Care System, Salt Lake City, UT (AJG); Program for Addiction Research, Clinical Care, Knowledge and Advocacy, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT (AJG); VA Puget Sound Health Care System, Seattle, WA (MAH); Department of Psychology, University of Washington, Seattle, WA (MAH); Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA (AJS, EJH); Center for Care Delivery and Outcomes Research, Health Services Research and Development, Minneapolis VA Health Care System, Minneapolis, MN (HJH); Department of Psychiatry, University of Minnesota, Minneapolis, MN (HJH); and Department of Health Services, University of Washington, Seattle, WA (GGS).
AN - 37579107
BT - J Addict Med
C5 - Education & Workforce;Opioids & Substance Use;HIT & Telehealth
CP - 4
DA - Jul-Aug 01
DO - 10.1097/adm.0000000000001156
DP - NLM
ET - 20230302
IS - 4
JF - J Addict Med
LA - eng
PY - 2023
SN - 1932-0620 (Print);1932-0620
SP - e262
EP - e268+
ST - Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation
T1 - Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation
T2 - J Addict Med
TI - Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation
U1 - Education & Workforce;Opioids & Substance Use;HIT & Telehealth
U3 - 10.1097/adm.0000000000001156
VL - 17
VO - 1932-0620 (Print);1932-0620
Y1 - 2023
ER -